Orlando North Dialysis in Orlando, Florida - Dialysis Center

Orlando North Dialysis is a medicare approved dialysis facility center in Orlando, Florida and it has 16 dialysis stations. It is located in Orange county at 5135 Adanson St Ste 700, Orlando, FL, 32804. You can reach out to the office of Orlando North Dialysis at (407) 539-3998. This dialysis clinic is managed and/or owned by Davita. Orlando North Dialysis has the following ownership type - Profit. It was first certified by medicare in September, 1996. The medicare id for this facility is 102707 and it accepts patients under medicare ESRD program.

Name	Orlando North Dialysis
Location	5135 Adanson St Ste 700, Orlando, Florida
No. of Dialysis Stations	16
Medicare ID	102707
Managed By	Davita
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Orlando North Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1770551012
Organization Name	Orlando North Dialysis
Doing Business As	Dva Renal Healthcare Inc
Address	5135 Adanson St Orlando, Florida, 32804
Phone Number	(407) 539-3998

Dialysis patients with Hemoglobin data

20

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	49
  Adult patient months included in Kt/V greater than or equal to 1.2	434
  Percentage of adult patients getting regular hemodialysis at the center
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Orlando North Dialysis with elevated calcium levels.

Patients with hypercalcemia	50
Hypercalcemia patient months	446
Hypercalcemia patients with serumcalcium greater than 10.2 mg
Patients with Serumphosphor	52
Patients with Serumphosphor less than 3.5 mg/dL
Patients with Serumphosphor from 3.5 to 4.5 mg/dL
Patients with Serumphosphor from 4.6 to 5.5 mg/dL
Patients with Serumphosphor from 5.6 to 7 mg/dL
Patients with Serumphosphor greater than 7 mg/dL

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	67
Patient months included in arterial venous fistula and catheter summaries	279
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary
Hospitalization Rate in facility	(Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit